ACS Medicinal Chemistry Letters · 2014 · 41 citations · 5 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryMolecular PharmacologyEnzyme InhibitionLead Compound DesignPotency OptimizationStructure-activity Relationship AnalysisCocrystal FormationMechanistic ProbesMicrosomal Incubation AssaysPhysicochemical PropertiesPi3k InhibitorsStructure-based Lead DiscoveryStructure-based ScreeningStructure-based Selectivity Design
A saturation strategy focused on improving the selectivity and physicochemical properties of ATR inhibitor HTS hit 1 led to a novel series of highly potent and selective tetrahydropyrazolo[1,5-a]pyrazines. Use of PI3Kα mutants as ATR crystal structure surrogates was instrumental in providing cocrystal structures to guide the medicinal chemistry designs. Detailed DMPK studies involving cyanide and GSH as trapping agents during microsomal incubations, in addition to deuterium-labeled compounds as mechanistic probes uncovered the molecular basis for the observed CYP3A4 TDI in the series.
5
Jean‐Damien Charrier, Steven J. Durrant, Julian M.C. Golec et al. · Journal of Medicinal Chemistry · 2011 · 259 citations · Full text
Kevin M. Foote, Kevin Blades, Anna Cronin et al. · Journal of Medicinal Chemistry · 2013 · 215 citations · Full text
Medicine, Oncology, Pharmacology +13
Simon Wong, Peter W. Fan, Raju Subramanian et al. · Drug Metabolism and Disposition · 2010 · 14 citations